Combination of Serum Neurofilament Light Chain and Serum Cardiac Troponin T as Biomarkers Improves Diagnostic Accuracy in Amyotrophic Lateral Sclerosis
Annals of Neurology · 2026
DOI: 10.1002/ana.78066 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Neurology, 2026. Verfasst von Paula Lindenborn und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuromuscular Diseases, Center for Neurology, University Hospital Bonn, Bonn, Germany. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Troponin T, Neurofilament Proteins. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
We aimed to evaluate the clinical utility of serum neurofilament light chain (sNfL) and cardiac troponin T (cTnT) in amyotrophic lateral sclerosis (ALS) and assess whether their combination improves diagnostic accuracy.
Methods
We retrospectively analyzed 293 ALS patients, 85 neurodegenerative disease controls, and 29 healthy controls. A validation cohort of 501 ALS patients was analyzed to confirm reproducibility of the results. Receiver operating characteristic (ROC) curve analysis was performed for sNfL, cTnT, and their combination, and the area under the curve (AUC) was compared across groups. An ALS‐specific cTnT cut‐off of 8.35ng/L was determined using the Youden index and applied in subgroup analyses, in which “biomarker‐negative” ALS patients were compared to “biomarker‐positive” patients regarding disease duration and progression. Results sNfL showed excellent performance in discriminating ALS patients from healthy controls (AUC = 0.94), but only moderate performance in discriminating neurodegenerative disease controls (AUC = 0.82). Combining sNfL and cTnT improved diagnostic accuracy for ALS over neurodegenerative controls, with an AUC of 0.90, whereas cTnT alone showed an AUC of 0.77. The validation cohort showed similar AUCs. “Biomarker‐negative” ALS patients had a longer disease duration (73.0 vs 18.0 months, p = 0.0003) and a lower progression rate (0.19 vs 0.70 points per months, p < 0.0001) than “biomarker‐positive” patients.
Interpretation
Although sNfL alone performs well in distinguishing ALS from healthy controls, repurposing cTnT for ALS provides additional value in discriminating ALS from disease controls. The combination of sNfL and cTnT improves diagnostic accuracy and may help identify prognostically distinct ALS subgroups. ANN NEUROL 2026;99:408–417
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neuromuscular Diseases, Center for Neurology, University Hospital Bonn, Bonn, Germany.
- Department of Parkinson, Sleep and Movement Disorders, Center for Neurology, University Hospital Bonn, Bonn, Germany.
- Department of Palliative Medicine, University Hospital Bonn, Bonn, Germany.
- Department of Neurology, Center for ALS and other Motor Neuron Disorders, Alfried Krupp Hospital, Essen, Germany.
- Department of Neurology, Center for ALS and Other Motor Neuron Disorders, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health…
- Ambulanzpartner Soziotechnologie APST, Berlin, Germany.
ORCID-Profile: Patrick Weydt
Zitieren
APA
Lindenborn, P., Fabian, R., Grehl, T., Nazlican, H., Meyer, T., Bernsen, S., & Weydt, P. (2026). Combination of Serum Neurofilament Light Chain and Serum Cardiac Troponin T as Biomarkers Improves Diagnostic Accuracy in Amyotrophic Lateral Sclerosis. Annals of Neurology. https://doi.org/10.1002/ana.78066
Vancouver
Lindenborn P, Fabian R, Grehl T, Nazlican H, Meyer T, Bernsen S, et al. Combination of Serum Neurofilament Light Chain and Serum Cardiac Troponin T as Biomarkers Improves Diagnostic Accuracy in Amyotrophic Lateral Sclerosis. Annals of Neurology. 2026. doi:10.1002/ana.78066
BibTeX
@article{Lindenborn2026,
author = {Lindenborn, Paula and Fabian, Rachel and Grehl, Torsten and Nazlican, Huelya and Meyer, Thomas and Bernsen, Sarah and Weydt, Patrick},
title = {Combination of Serum Neurofilament Light Chain and Serum Cardiac Troponin T as Biomarkers Improves Diagnostic Accuracy in Amyotrophic Lateral Sclerosis},
journal = {Annals of Neurology},
year = {2026},
doi = {10.1002/ana.78066}
}
EUVIMED